New Key Statistics Module, Z-Score and F-Score
NAS:INM Key Ratios
| Market Cap $ M | 2.08 |
| Enterprise Value $ M | -4.53 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.15 |
| Price/Sales | 0.20 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 5.00 |
| EPS (TTM) $ | -0.85 |
| Beneish M-Score | -1.83 |
| 10-y EBITDA Growth Rate % | 7.30 |
| 5-y EBITDA Growth Rate % | 50.00 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 0.68 |
| EV-to-EBITDA | 0.75 |
| PEG | -- |
| Shares Outstanding M | 8.36 |
| Net Margin (%) | -108.00 |
| Operating Margin % | -118.04 |
| Pre-tax Margin (%) | -107.98 |
| Quick Ratio | 5.80 |
| Current Ratio | 6.58 |
| ROA % (ttm) | -44.44 |
| ROE % (ttm) | -52.44 |
| ROIC % (ttm) | -156.72 |
| Dividend Yield % | -- |
| Altman Z-Score | -11.01 |
INM Number of Guru Trades
INM Volume of Guru Trades
Gurus Latest Trades with NAS:INM
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:INM is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
InMed Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:INM
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers